Personal information

Other IDs

SciProfiles: 1353897

Activities

Collapse all

Works (6)

Comparison between N-803 and Erdafitinib in Bacillus Calmette-Guérin-Unresponsive Non-Muscle-Invasive Bladder Cancer

Cancers
2024-10-11 | Journal article
DOI: 10.3390/cancers16203445
Contributors: Anusha Gupta; Shiv Verma; Sanjay Gupta
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Chimeric Antigen Receptor-Modified T Cell Therapy in Metastatic Castrate-Resistant Prostate Cancer: Promise and Potential

Cancers
2024-03 | Journal article | Author
DOI: 10.3390/cancers16051053
Contributors: Leah Tharian; Shiv Verma; Sanjay Gupta
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer

Cancers
2024-01 | Journal article | Author
DOI: 10.3390/cancers16020246
Contributors: Shiv Verma; Diya Swain; Prem Prakash Kushwaha; Smit Brahmbhatt; Karishma Gupta; Debasish Sundi; Sanjay Gupta
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Gut Microbiome and Risk of Lethal Prostate Cancer: Beyond the Boundaries

Cancers
2023-12 | Journal article | Author
DOI: 10.3390/cancers15235681
Contributors: Pranav Prakash; Shiv Verma; Sanjay Gupta
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Does ADT Influence the Risk of Suicidal Ideation among US Veteran Prostate Cancer Patients Pre-Exposed to PTSD?

Cancers
2023-05 | Journal article | Author
DOI: 10.3390/cancers15102739
Contributors: Smit Brahmbhatt; Herta Chao; Shiv Verma; Sanjay Gupta
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Aquaporins as Prognostic Biomarker in Prostate Cancer

Cancers
2023-01 | Journal article | Author
DOI: 10.3390/cancers15020331
Contributors: Prem Prakash Kushwaha; Shiv Verma; Sanjay Gupta
Source: check_circle
Multidisciplinary Digital Publishing Institute
grade
Preferred source (of 2)‎

Peer review (7 reviews for 1 publication/grant)

Review activity for Molecular medicine. (7)
How many people are using ORCID?